Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.1.1.u2
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation
Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:
Three Months Ended March 31,
Stock-based compensation 2024 2023
Cost of revenues $ 45  $ 253 
Sales and marketing 14  97 
General and administrative 556  859 
Research and development 15  153 
Total stock-based compensation $ 630  $ 1,362 
Schedule of Restricted Stock Unit Activity
A summary of our restricted stock unit activity for the three months ended March 31, 2024 is set forth below:
Shares Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2023 96,808  $ 25.21 
Granted 9,032  4.13 
Released (27,453) 17.25 
Forfeited —  — 
Outstanding as of March 31, 2024 78,387  $ 25.58 
Schedule of Stock Option Activity
A summary of our stock option activity under the 2018 Equity Incentive Plan (the "2018 Plan) and related information is as follows:
Number of Shares Weighted Average
Exercise Price
Weighted Average
Remaining
Contractual Term
(years)
Aggregate Intrinsic
Value
Outstanding as of December 31, 2023 2,500  $ 56.89  4.2 $ — 
Granted —  — 
Exercised —  — 
Forfeited —  — 
Outstanding as of March 31, 2024 2,500  $ 56.89  3.9 $ — 
Exercisable as of March 31, 2024 2,500  $ 56.89  3.9 $ — 
A summary of our option activity under our 2009 Equity Incentive Plan (the "2019 Plan") and related information is as follows:
Number of Shares Weighted Average
Exercise Price
Weighted Average
Remaining
Contractual Term
(years)
Aggregate Intrinsic
Value
Outstanding as of December 31, 2023 14,625  $ 39.67  2.9 $ — 
Granted —  — 
Exercised —  — 
Forfeited (4,114) 44.54 
Outstanding as of March 31, 2024 10,511  $ 37.77  3.8 $ — 
Exercisable as of March 31, 2024 10,511  $ 37.77  3.8 $ —